US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction With the Overall Face and Neck Appearance After Combined Treatment
Latest Information Update: 06 Feb 2025
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Deoxycholic acid (Primary)
- Indications Glabellar lines; Nasolabial fold
- Focus Therapeutic Use
- Acronyms US HARMONY in DIVERSITY
- Sponsors AbbVie
- 23 Jan 2025 New trial record